达纳项目:公开传播 (纳米) 材料安全数据 - - 从阴谋论到研究质量理论
Dana Kühnel1, Harald F Krug2, Christoph Steinbach3
1Helmholtz Centre for Environmental Research (UFZ), Department Ecotoxicology (ETOX), Leipzig, Germany.
这个视角分享了传达纳米材料安全的经验,突出了DaNa项目 (2009-2023年). 基于事实的方法促进了公众的信任,并促进了对纳米材料的科学理解.
科学领域:
- 材料科学 材料科学 材料科学
- 科学传播科学传播
- 风险评估 风险评估
背景情况:
- 向公众传达纳米材料的安全性是在21世纪初诞生,这带来了重大挑战.
- 从2009年到2023年,DaNa系列项目 (DaNa,DaNa2.0,DaNa4.0) 解决了这些早期的通信障碍.
- 科学传播现在被认为是传播科学发现的关键.
研究的目的:
- 为了分享长期的经验和发展,沟通 (纳米) 材料安全.
- 为未来的科学传播倡议提供有用的见解.
- 展示基于事实的方法对公众对话的影响.
主要方法:
- 长期项目系列 (DaNa,DaNa2.0,DaNa4.0) 记录了沟通策略和成果.
- 开发一个"知识基础材料",以建立一个值得信赖的公共对话.
- 分析在传达复杂科学信息方面的挑战和成功.
主要成果:
- 达纳系列项目代表了对纳米材料安全沟通的公开资助努力的重大,潜在的世界领先的贡献.
- 建立了基于事实的科学传播的成功模式,培养了公众的信任.
- 展示了科学传播在纳米技术中的演变和日益重要的重要性.
结论:
- 长期的专用项目在推进科学传播实践方面是有效的.
- 基于事实的"知识基础"方法对于建立公众对科学研究的信任至关重要.
- 分享的经验为有关新兴材料的持续和未来的科学传播努力提供了宝贵的教训.
更多相关视频
07:47Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering
Published on: September 16, 2016
07:08Nanoparticle Tracking Analysis of Gold Nanoparticles in Aqueous Media through an Inter-Laboratory Comparison
Published on: October 20, 2020
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
The Scientific Method
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Hazard Ratio
For example, in a clinical trial...
